Ucb, S.A.
UCB, S.A. is named on 0 US grants and 8 published applications in this corpus. Its most frequent classification is A61P (Therapeutic uses of medicines).
- Granted patents
- 0
- Published applications
- 8
- Inventors
- 40
- Granted in 2026 so far
- 0
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 4 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
By publication year.
Technology areas
Share of 8 documents
- A61PTherapeutic uses of medicines5
- C07DHeterocyclic compounds4
- A61KMedicines and medical preparations2
- C07KPeptides1
- C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients1
- C09DCoating compositions1
- C12NMicroorganisms or enzymes1
- G01NInvestigating or analysing materials by determining their chemical or physical properties1
- Y10TTechnical subjects covered by former us classification1
Recent patents
No granted patents yet.
- Compositions and methods for diagnosing or treating psoriasis11 Mar 2010US 2010/0063259 A1
- Imidazole derivatives, processes for preparing them and their uses3 Apr 2008US 2008/0081832 A1
- Pyrrolidinone derivatives12 Aug 2004US 2004/0157914 A1
- Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases3 Jun 2004US 2004/0106147 A1
- Thermosetting power compositions for the preparation of low-gloss coatings15 Apr 2004US 2004/0071955 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.